Characterization of a fucoidan from Lessonia vadosa (Phaeophyta) and its anticoagulant and elicitor properties
- PMID: 18054382
- DOI: 10.1016/j.ijbiomac.2007.10.023
Characterization of a fucoidan from Lessonia vadosa (Phaeophyta) and its anticoagulant and elicitor properties
Abstract
Blades of Lessonia vadosa (Phaeophyta) were extracted with 2% CaCl(2) solution, affording in 4.4% yield a polysaccharide which contained fucose and sulfate groups in the molar ratio 1.0:1.12. The high negative optical activity value ([alpha](D)(22)=-134.0 degrees ), FT-IR and NMR analysis suggest the presence of a fucoidan. (13)C NMR spectrum of the polysaccharide obtained by solvolytic desulfation of native fucoidan indicated the major presence of 1-->3 linked alpha-l-fucan. Depolymerization of the native fucoidan with H(2)O(2) in the presence of copper(II) acetate gave in 54.8% yield a fraction with 33.7% of sulfate content. The native fucoidan (MW 320,000) showed good anticoagulant activity whereas the radical depolymerized fraction (MW 32,000) presented a weak anticoagulant activity. These polysaccharides showed significant activation of phenylalanine-ammonia lyase (PAL), lipooxygenase (LOX) and glutathione-S-transferase (GST) defence enzyme activities in tobacco plants.
Similar articles
-
A study of fucoidan from the brown seaweed Chorda filum.Carbohydr Res. 1999 Jul 20;320(1-2):108-19. doi: 10.1016/s0008-6215(99)00148-2. Carbohydr Res. 1999. PMID: 10515064
-
A fucoidan fraction from Ascophyllum nodosum.Carbohydr Res. 2001 Nov 8;336(2):155-9. doi: 10.1016/s0008-6215(01)00257-9. Carbohydr Res. 2001. PMID: 11689185
-
Sulfated galactofucan from Lobophora variegata: anticoagulant and anti-inflammatory properties.Biochemistry (Mosc). 2008 Sep;73(9):1018-24. doi: 10.1134/s0006297908090095. Biochemistry (Mosc). 2008. PMID: 18976219
-
Important determinants for fucoidan bioactivity: a critical review of structure-function relations and extraction methods for fucose-containing sulfated polysaccharides from brown seaweeds.Mar Drugs. 2011;9(10):2106-2130. doi: 10.3390/md9102106. Epub 2011 Oct 24. Mar Drugs. 2011. PMID: 22073012 Free PMC article. Review.
-
Possibilities of Fucoidan Utilization in the Development of Pharmaceutical Dosage Forms.Mar Drugs. 2019 Aug 5;17(8):458. doi: 10.3390/md17080458. Mar Drugs. 2019. PMID: 31387230 Free PMC article. Review.
Cited by
-
Marine polysaccharides from algae with potential biomedical applications.Mar Drugs. 2015 May 15;13(5):2967-3028. doi: 10.3390/md13052967. Mar Drugs. 2015. PMID: 25988519 Free PMC article. Review.
-
Fucoidan from Undaria pinnatifida Ameliorates Epidermal Barrier Disruption via Keratinocyte Differentiation and CaSR Level Regulation.Mar Drugs. 2019 Nov 24;17(12):660. doi: 10.3390/md17120660. Mar Drugs. 2019. PMID: 31771286 Free PMC article.
-
Anti-phytopathogenic activities of macro-algae extracts.Mar Drugs. 2011;9(5):739-756. doi: 10.3390/md9050739. Epub 2011 May 3. Mar Drugs. 2011. PMID: 21673886 Free PMC article.
-
Inhibition of Influenza A Virus Infection by Fucoidan Targeting Viral Neuraminidase and Cellular EGFR Pathway.Sci Rep. 2017 Jan 17;7:40760. doi: 10.1038/srep40760. Sci Rep. 2017. PMID: 28094330 Free PMC article.
-
Brown Seaweed Fucoidan in Cancer: Implications in Metastasis and Drug Resistance.Mar Drugs. 2020 Apr 28;18(5):232. doi: 10.3390/md18050232. Mar Drugs. 2020. PMID: 32354032 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials